Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb;60(1):102956.
doi: 10.1016/j.transci.2020.102956. Epub 2020 Sep 24.

Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia

Affiliations
Case Reports

Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia

Ravi Shankar et al. Transfus Apher Sci. 2021 Feb.

Abstract

The natural history of COVID-19 infection in children is still evolving as the pandemic unfolds. Few cases of severe and often fatal COVID-19 have been reported although the infection is mild in the large majority. Children with cancers are recognised as a high risk group for all infections. Since there aren't any definite treatment guidelines established in children with severe COVID, treatment is guided by adult recommendations which too are often not evidence based. We report the case of a 4-year-old girl with severe COVID-19 associated pneumonia who presented to us as febrile neutropenia. The use of convalescent plasma along with steroids and IVIG showed dramatic results in this child and she recovered without the need for any specific treatment. This is highlighted as one of the earliest cases that is reporting the use of convalescent plasma in a child; the first ever in a child with underlying malignancy.

Keywords: COVID-19; COVID-19 convalescent plasma; COVID-19 in paediatrics; COVID-19 pneumonia; COVID-19 with acute lymphoblastic leukemia.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Chronological history of the presentations and treatment of the patient.

References

    1. Kaspers G.J.L. COVID-19: how will this impact children with cancer, now and in the future? Expert Rev Anticancer Ther. 2020;20(7):527–529. - PubMed
    1. Stokes C.L., Patel P.A., Sabnis H.S., Mitchell S.G., Yildirim I.B., Pauly M.G. Severe COVID-19 disease in two pediatric oncology patients. Pediatr Blood Cancer. 2020;67(9) - PMC - PubMed
    1. Oualha M., Bendavid M., Berteloot L., et al. Severe and fatal forms of COVID-19 in children. Arch Pediatr. 2020;27(5):235–238. - PMC - PubMed
    1. Ferrari A., Zecca M., Rizzari C., et al. Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy. Pediatr Blood Cancer. 2020;67(8) - PMC - PubMed
    1. Flores V., Miranda R., Merino L., et al. SARS-CoV-2 infection in children with febrile neutropenia. Ann Hematol. 2020;99(8):1941–1942. - PMC - PubMed

Publication types

MeSH terms